Who Are We
Cothera Bioscience is an innovation-oriented pharmaceutical company committed to cancer drug discovery and individualized cancer medicine. The company is equipped with an i-CR® tumor primary cell drug screening platform, a technological setup with independent intellectual property rights, which features a higher clinical relevance compared to traditional in vitro drug testing methods. Focusing on the area of synthetic lethality and immuno-oncology, the company has developed a series of new drugs. Many international and domestic patents have been applied based on in-house scientific research, and formal clinical trials for some products have been launched in several countries.
Percans Oncology is a subsidiary of Cothera Bioscience in medical oncology research and drug development. The company possesses a 400m2 cell culture laboratory and an 800m2 standard SPF animal facility. The company has established a complete in vivo/in vitro pharmacodynamics evaluation platform, tumor primary cell culture and high-throughput drug screening platform.